Best Practices in Vendor and Project Management

Today’s Top Three in Pharma 041009

J&J cutting 900 positions, mostly in sales – Diversified healthcare company Johnson & Johnson said on Thursday it was eliminating 900 positions from its Ortho-McNeil-Janssen Pharmaceutical unit in the latest downsizing move in the drug industry. The reductions occurred across Ortho-McNeil-Janssen, but the majority of the jobs impacted were from sales, spokeswoman Kara Russell said.

More big-name hospital systems limiting drug industry ties – Just a few days after Johns Hopkins announced a stricter conflict-of-interest policy for its doctors, some big-name Massachusetts hospitals are moving in a similar direction. Doctors at Partners HealthCare, a system that includes Harvard-affiliated Mass General and Brigham and Women’s hospitals as well as outpatient clinics, will be barred from accepting free meals from drug makers. They will also be prohibited from serving on drug-company “speakers’ bureaus,” where doctors are paid to give talks to other doctors.

Share this:

Like this:

Welcome!

Steve Woodruff
President, Impactiviti

Testimonials

“Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics